Corium Reports First Quarter Fiscal 2015 Financial Results
MENLO PARK, Calif., Feb. 10, 2015 (GLOBE NEWSWIRE) — Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced unaudited financial results from operations…